| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 868 | 3.607 | 1.547 | 678 | 165 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 901 | 3.610 | 1.547 | 678 | 167 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 3.936 | 6.092 | 2.494 | 1.038 | 358 | 5 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | -3.036 | -2.482 | -947 | -361 | -191 | -5 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | -3.062 | -2.590 | -993 | -381 | -196 | -5 | 0 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cumpara Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 113 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 4.403 | 4.055 | 2.293 | 1.869 | 1.669 | 1.283 | 1.287 | 1.284 | 1.276 |
| Inventories | - | 4.004 | 3.062 | 1.835 | 1.453 | 1.312 | 1.283 | 1.287 | 1.283 | 1.276 |
| Receivables | - | 128 | 14 | 0 | 12 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 271 | 979 | 458 | 403 | 357 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | -3.017 | -5.556 | -6.447 | -6.703 | -6.772 | -6.627 | -6.647 | -6.627 | -6.590 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.678 | 9.724 | 8.740 | 8.572 | 8.441 | 7.910 | 7.935 | 7.911 | 7.867 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Cumpara Bio Srl